Increased levels of 14-3-3 gamma and epsilon proteins in brain of patients with Alzheimer's disease and Down Syndrome

Journal of Neural Transmission, Supplement

Volumn , Issue 57, 1999, Pages 323-335

  Fountoulakis, M ^a   Cairns, N ^c   Lubec, G ^b  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b UNIVERSITY OF VIENNA   (Austria)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

14 3 3 EPSILON PROTEIN; 14 3 3 GAMMA PROTEIN; ADAPTOR PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN 14 3 3; PROTEIN BCL 2; PROTEIN KINASE C; RAS PROTEIN; UNCLASSIFIED DRUG; ISOPROTEIN; PEPTIDE FRAGMENT; PROTEIN; TYROSINE 3 MONOOXYGENASE;

ADULT; AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; AMINO ACID SEQUENCE; BRAIN; BRAIN LEVEL; CEREBELLUM; CHEMISTRY; COMPARATIVE STUDY; DIMERIZATION; FRONTAL LOBE; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; OCCIPITAL LOBE; PARIETAL LOBE; PATHOLOGY; REFERENCE VALUE; TEMPORAL LOBE;

14-3-3 PROTEINS; AGED; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; BRAIN; BRAIN CHEMISTRY; CEREBELLUM; DIMERIZATION; DOWN SYNDROME; FEMALE; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OCCIPITAL LOBE; PARIETAL LOBE; PEPTIDE FRAGMENTS; PROTEIN ISOFORMS; PROTEINS; REFERENCE VALUES; TEMPORAL LOBE; TYROSINE 3-MONOOXYGENASE;

EID: 0032585827     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6380-1_23     Document Type: Article

References (54)

1. Aitken A, Howell S, Jones D, Madrazo J, Martin H, Patel Y, Robinson K (1995) Posttranslationally modified 14-3-3 isoforms and inhibition of protein kinase C. Mol Cell Biochem 149: 41-49
2. Becker L, Mito T, Takashima S, Onodera K (1991) Growth and development of the brain in Down Syndrome. Progr Clin Biol Res 373: 133-152
3. Bernert G, Nemethova M, Cairns N, Lubec G (1996) Decreased cyclin dependent kinase in brain of patients with Down Syndrome. Neurosci Lett 216: 68-70
4. Beyreuther K, Pollwein P, Multhaup G, Monning U, Konig G, Dyrks T, Schubert W, Masters DL (1993) Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease, and Down's Syndrome. Ann NY Acad Sci 695: 91-102
5. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
6. Braselmann S, McCormick F (1995) Bcr and Raf form a complex in vivo via 14-3-3 proteins. EMBO J 14: 4839-4848
7. Broadie K, Rushton E, Skoulakis EM, Davis RL (1997) Leonardo, a Drosophila 14-3-3 protein involved in learning, regulates presynaptic function. Neuron 19: 391-402
8. Chamberlain LH, Roth D, Morgan A, Burgoyne RD (1995) Distinct effects of alpha-SNAP, 14-3-3 proteins, and calmodulin on priming and triggering of regulated exocytosis. J Cell Biol 130: 1063-1070
9. Chang HC, Rubin GM (1997) 14-3-3 epsilon positively regulates Ras - mediated signaling in Drosophila. Genes Dev 11: 1132-1139
10. Chen F, Wagner PD (1994) 14-3-3 proteins bind to histone and affect both histone phosphorylation and dephosphorylation. FEBS Lett 347: 128-132
11. Conklin DS, Galaktionov K, Beach D (1995) 14-3-3 proteins associate with cdc25 phosphatases. Proc Natl Acad Sci USA 92: 7892-7896
12. Craparo A, Freund R, Gustafson TA (1997) 14-3-3 (epsilon) interacts with the insulin-like growth factor receptor and insulin receptor substrate-1 in a phosphoserine - dependent manner. J Biol Chem 272: 11663-11669
13. Dawbarn D, Allen SJ (1995) Neurobiology of Alzheimer's disease. Bios Scientifique Publishers, Oxford
14. Dubois T, Howell S, Amess B, Kerai P, Learmonth M, Madrazo J, Chaudhri M, Rittinger K, Scarabel M, Soneji Y, Aitken A (1997) Structure and sites of phosphorylation of 14-3-3 protein: role in coordinating signal transductiion pathways. J Protein Chem 16: 513-522
15. Fanger GR, Widman C, Porter AC, Sather S, Johnson GL, Vaillancourt RR (1998) 14-3-3 proteins interact with specific MEK kinases. J Biol Chem 273: 3476-3483
16. Fantl WJ, Muslin AJ, Kikuchi A, Martin JA, MacNicol AM, Gross RW, Williams LT (1994) Activation of Raf by 14-3-3 proteins. Nature 371: 612-614
17. Freed E, Symons M, Macdonald SG, McCormick F, Ruggieri R (1994) Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation. Science 265: 1713-1716
18. Fountoulakis M, Langen H (1997) Identification of proteins by matrix-assisted laser desorption ionization-mass spectroscopy following in-gel digestion in low-salt, non-volatile buffer and simplified peptide recovery. Anal Biochem 250: 153-156
19. Greber S, Lubec G, Cairns N, Fountoulakis M (1999) Decreased synaptosomal associated protein 25 levels in brain of patients with Down Syndrome and Alzheimer's disease. Electrophoresis (in press)
20. Hsieh G, Kenney K, Gibbs CJ, Lee KH, Harrington MG (1996) The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 335: 924-930
21. Hsu SY, Kaipia A, Zhu L, Hsueh AJ (1997) Interference of BAD (Bcl-xL/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and P11. Mol Encodrinol 11: 1858-1867
22. Ichimura T, Ito M, Itagaki C, Takahashi M, Horigome T, Omata S, Ohno S, Isobe T (1997) The 14-3-3 proteins bind its target protein with a common site located towards the C-terminus. FEBS Lett 413: 273-276
23. Isobe T, Hiyane Y, Ichimura T, Okuyama T, Takahashi N, Nakajo S, Nakaya K (1992) Activation of protein kinase C by the 14-3-3 proteins homologous with Exo1 protein that stimulates calcium dependent exocytosis. FEBS Lett 308: 121-124
24. Jones DH, Martin H, Madrazo J, Robinson KA, Nielsen P, Roseboom PH, Patel Y, Howell SA, Aitken A (1995) Expression and structural analysis of 14-3-3 proteins. J Mol Biol 245: 375-384
25. Kumagai A, Yakowec PS, Dunphy WG (1998) 14-3-3 proteins act as negative regulators of the mitotic inducer Cdc25 in Xenopus egg extracts. Mol Biol Cell 9: 345-354
26. Langen H, Roeder D, Juranville J-F, Fountoulakis M (1997) Effect of the protein application mode and the acrylamide concentration on the resolution of protein spots separated by two-dimensional gel electrophoresis. Electrophoresis 18: 2085-2090
27. Layfield R, Fergusson J, Aitken A, Lowe J, Landon M, Mayer RJ (1996) Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins. Neurosci Lett 209: 57-60
28. Lee KH, Harrington MG (1997) The assay development of a molecular marker for transmissible sponsiform encephalopathies. Electrophoresis 18: 502-506
29. Liao J, Omary MB (1996) 14-3-3 proteins associate with phosphorylated simple epithelial keratins during cell cycle progression and act as a solubility cofactor. J Cell Biol 133: 345-357
30. Martin H, Rostas J, Patel Y, Aitken A (1994) Subcellular localisation of 14-3-3 isoforms in rat brain using specific antibodies. J Neurochem 63: 2259-2265
31. Mirra SS, Heyman A, McKeel D, Sumi S, Grain BJ (1991) The consortium to establish a registry for Alzheimer disease (CERAD). II. Standardisation of the neuropathological assessment of Alzheimer's disease. Neurology 41: 479-486
32. Muslin AJ, Tanner JW, Allen PM, Shaw AS (1996) Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84: 889-897
33. Ogihara T, Isobe T, Ichimura T, Taoka M, Funaki M, Sakoda H, Onishi Y, Inukai K, Anai M, Fukushima Y, Kikuchi M, Yazaki Y, Oka Y, Asano T (1997) 14-3-3 protein binds to insulin receptor substrate-1, one of the binding sites of which is in the phosphotyrosine binding domain. J Biol Chem 272: 25267-25274
34. Peng CY, Graves RR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H (1997) Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine 216. Science 277: 1501-1505
35. Petit TL, LeBoutillier JC, Alfano DP, Becker LE (1984) Synaptic development in the human fetus: a morphometric analysis of normal and Down's syndrome neocortex. Exp Neurol 83: 13-23
36. Pietromonaco SF, Seluja GA, Aitken A, Elias L (1996) Association of 14-3-3 proteins with centrosomes. Blood Cells Mol Dis 22: 225-237
37. Robinson K, Jones D, Patel Y, Martin H, Madrazo J, Martin S, Howell S, Elmore M, Finnen MJ, Aitken A (1994) Mechanisms of inhibition of protein kinase C by 14-3-3 isoforms. 14-3-3 isoforms do not have phospholipase A2 activity. Biochem J 299: 853-861
38. Rommel C, Radziwill G, Lovric J, Noeldeke J, Heinicke T, Jones D, Aitken A, Moelling K (1996) Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1. Oncogene 12: 609-619
39. Rosenmann H, Meiner Z, Kahana E, Halimi M, Lenetsky E, Abramsky O, Gabizon R (1997) Detection of 14-3-3 protein in the CSF of genetic Creutzfeld-Jakob disease. Neurology 49: 593-595
40. Roth D, Morgan A, Burgoyne RD (1993) Identification of a key domain in annexin and 14-3-3 proteins that stimulate calcium dependent exocytosis in permeabilized adrenal chromaffin cells. FEBS Lett 320: 207-210
41. Seidl R, Greber S, Schuller E, Bernert G, Cairns N, Lubec G (1997) Evidence against increased oxidative DNA-damage in Down Syndrome. Neurosci Lett 235: 137-140
42. Skoulakis EM, Davis RL (1996) Olfactory learning deficits in mutants for Leonardo, a drosophila gene encoding a 14-3-3 protein. Neuron 17: 931-944
43. Tanji M, Horwitz R, Rosenfeld G, Waymire JC (1994) Activation of protein kinase C by purified bovine brain 14-3-3: comparison with tyrosine hydroxylase activation. J Neurochem 63: 1908-1916
44. Tierney MC, Fisher RH, Lewis AJ, Torzitto ML, Snow WG, Reid DW, Nieuwstraaten P, Van Rooijen LAA, Derks HJGM, Van Wijk R, Bischop A (1988) The NINCDA-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease. Neurology 38: 359-364
45. Toker A, Ellis CA, Sellers LA, Aitken A (1990) Protein kinase C inhibitor proteins. Purification from sheep brain and sequence similarity to lipocortins and 14-3-3 proteins. Eur J Biochem 191: 421-429
46. Toker A, Sellers LA, Amess B, Patel Y, Harris A, Aitken A (1992) Multiple isoforms of a protein kinase C inhibitor (KCIP-1/14-3-3) from sheep brain. Eur J Biochem 206: 453-461
47. Vincenz C, Dixit VM (1996) 14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecule. J Biol Chem 271: 20029-20034
48. Wang HG, Takayama S, Rapp UR, Reed JC (1996) Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc Natl Acad Sci 93: 7063-7068
49. Watanabe M, Isobe T, Ichimura T, Kuwano R, Takahashi Y, Kondo H (1993) Molecular cloning of rat cDNAs for beta and gamma subtypes of 14-3-3 proteins and developmental changes in expression of their mRNAs in the nervous system. Brain Res Mol Brain Res 17: 135-146
50. Weber T, Otto M, Bodemer M, Zerr I (1997) Diagnosis of Creutzfeld - Jakob disease and related human spongiform encephalopathies. Biomed Pharmacother 51: 381-387
51. Xing H, Kornfeld K, Muslin AJ (1997) The protein kinase KSR interacts with 14-3-3 protein and Raf. Curr Biol 7: 294-300
52. Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, Leffers H, Gamblin SJ, Smerdon SJ, Cantley SC (1997) The structural basis for 14-3-3: phosphopeptide binding specificity. Cell 91: 961-971
53. Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretschmar HA, Weber T (1998) Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeld-Jakob disease. Ann Neurol 43: 32-40
54. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87: 619-628